Citius Pharmaceuticals (CTXR) Share-based Compensation (IS) (2014 - 2026)
Citius Pharmaceuticals (CTXR) posted Share-based Compensation (IS) of $3.81 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 24.5% from $3.06 million a year earlier and up 128.4% from the prior quarter.
Citius Pharmaceuticals (CTXR) Share-based Compensation (IS) (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation (IS) at Citius Pharmaceuticals was $11.4 million, up 14.8% year-over-year; for FY2025 (ended Sep 30, 2025), it was $10.84 million, unchanged from FY2024.
- In prior fiscal years, Citius Pharmaceuticals' Share-based Compensation (IS) was $10.84 million in FY2024 (+63.8%) and $6.62 million in FY2023.
- Quarterly Share-based Compensation (IS) has run from a low of $1.17 million in fiscal Q2 2023 to a high of $4.28 million in fiscal Q1 2026 over five years.
- On a year-over-year basis, Share-based Compensation (IS) increased in three of the last eight quarters, with growth averaging 19.8%.
- The strongest year-over-year quarter for Share-based Compensation (IS) in the past five years was fiscal Q2 2024, with growth of 164.1%; the weakest was fiscal Q3 2024, with a decline of 40.0%.
- According to Business Quant data, Share-based Compensation (IS) for the three prior fiscal quarters was $1.67 million (Q2 2026), $4.28 million (Q1 2026) and $1.64 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Citius Pharmaceuticals | 13.45 Mn | -10.82 Mn | 1.00 Mn | 3.81 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.81 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 976,675.00 |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 904,604.00 |
| Sep 30, 2021 | 461,865.00 |
| Jun 30, 2021 | 373,570.00 |
| Mar 31, 2021 | 342,962.00 |
Citius Pharmaceuticals Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();